Evaluate the Efficacy and Safety of LMT1-48 on Reducing Body Fat in Overweight Subject

Medy-Tox97 enrolled

Overview

The purpose of this study is to evaluate the safety and efficacy of LMT1-48(Probiotics) compared to a placebo in reducing the body fat in overweight subjects

Study Type

INTERVENTIONAL

Allocation

RANDOMIZED

Purpose

TREATMENT

Masking

QUADRUPLE

Enrollment

Conditions

Overweight

Interventions

LMT1-48DIETARY_SUPPLEMENT

capsules containing Probiotics

PlaceboDIETARY_SUPPLEMENT

capsules that did not contain any probiotics

Eligibility

Sex: ALLMin age: 19 YearsMax age: 70 Years

Medical Language ↔ Plain English

Inclusion Criteria: * Age between 19 and 70 years * Overweight (25 kg/m2 ≤ body mass index (BMI) \< 30 kg/m2) Exclusion Criteria: * Pregnancy or breast-feeding * Unstable body weight (body weight change \> 10% within 3 months before screening)

Locations (1)

Seoul National University Bundang Hospital

Seongnam-si, South Korea

Outcomes

Primary Outcomes

change from baseline fat percentage at 12 week

the body composition of the subjects was measured via dual-energy X-ray absorptiometry (DEXA) to determine

Time frame: at baseline and 12-week follow-up

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.